Y-Intercept (HK)’s Kronos Bio KRON Stock Holding History

Y-Intercept (HK)’s Portfolio KRON Stock Details KRON Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2023 Q3	–	Sell	-57,952	Closed	-$99.7K	–	1347
2023 Q2	$99.7K	Buy	+57,952	New	+$92K	0.01%	1100

Other funds holding KRON

Omega Fund Management Boston, Massachusetts $163M AUM 107.06% 1-Year Est. Return

BVF Inc San Francisco, California $3.14B AUM 249.53% 1-Year Est. Return

Vida Ventures Advisors Boston, Massachusetts $29.4M AUM 93.58% 1-Year Est. Return

Perceptive Advisors New York $5.12B AUM 314.02% 1-Year Est. Return

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

Partners Capital Investment Group Boston, Massachusetts $2.65B AUM 16.42% 1-Year Est. Return

Artal Group Luxembourg $1.01B AUM 29.84% 1-Year Est. Return

Nextech Invest Zurich, Switzerland $1.42B AUM 304.47% 1-Year Est. Return

Alphabet Inc Mountain View, California $4.02B AUM 215.74% 1-Year Est. Return

BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return

Y-Intercept (HK)'s KRON Position: Q3 2023 in Review

Y-Intercept (HK) sold out of Kronos Bio (KRON) in Q3 2023, closing a stake of 57,952 shares — an estimated $99.7K sold.

Y-Intercept (HK) first reported a position in KRON in Q2 2023 and held it in 1 quarter. The position peaked at $99.7K in Q2 2023. 63 funds tracked by Wall St. Rank hold KRON as of Q3 2023.

Y-Intercept (HK) reported no remaining Kronos Bio position as of Q3 2023 after selling out during the quarter.
Y-Intercept (HK) sold 57,952 Kronos Bio shares in Q3 2023, an estimated $99.7K.
Y-Intercept (HK) first reported a position in Kronos Bio in Q2 2023 and held it in 1 quarter.
Y-Intercept (HK)'s Kronos Bio position peaked at $99.7K in Q2 2023.
63 funds tracked by Wall St. Rank held Kronos Bio as of Q3 2023.

Based on Y-Intercept (HK)'s 13F filing for Q3 2023, filed 14 Nov 2023.